Reduced sociability in a prenatal immune activation model: Modulation by a chronic blonanserin treatment through the amygdala-hippocampal axisJOURNAL OF PSYCHIATRIC RESEARCHIF3.22023-08-011OAAI
Early effects of lurasidone treatment in a chronic mild stress model in male ratsPSYCHOPHARMACOLOGYIF3.32023-02-236OAAI
Exposure to chronic stress impairs the ability to cope with an acute challenge: Modulation by lurasidone treatmentEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72022-08-017OAAI
Acute stress differentially regulates BDNF expression in prefrontal excitatory and inhibitory neurons of chronically stressed rats: modulation by lurasidone treatmentEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
Sex-dependent effects of a chronic treatment with lurasidone on the vulnerability to chronic stress exposureEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
Exposure to prenatal stress induces sex-specific vulnerability in adolescent ratsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
The early therapeutic efficacy of lurasidone in a rodent model of depression: a behavioural and biomolecular studyEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-12-010PRE
Long-lasting effects of prenatal stress on HPA axis and inflammation: A systematic review and multilevel meta-analysis in rodent studiesNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92021-08-0132OAAI
Time course of antidepressant actions of lurasidone treatment towards the identification of early biomarkers of responseEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-03-010PREAI
Prenatal stress induces sex-specific behavioural and excitatory/inhibitory balance alterations in adult ratsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72021-03-010PREAI
Behavioral and molecular effects of the antipsychotic drug blonanserin in the chronic mild stress modelPHARMACOLOGICAL RESEARCHIF10.52021-01-0110PREAI
Amygdala and prefrontal cortex excitatory/inhibitory balance in a rat model of prenatal stress exposureEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72020-11-010PREAI
Chronic treatment with the antipsychotic drug blonanserin modulates the responsiveness to acute stress with anatomical selectivityPSYCHOPHARMACOLOGYIF3.32020-04-1513PREAI
Neuroplastic changes following chronic treat-ment with antipsychotic blonanserin in rats: Implications for schizophreniaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-12-010PREAI
Neuroplastic changes following chronic treatment with antipsychotic blonanserin in rats: Implications for schizophreniaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72019-01-010PREAI
JNK1 controls adult hippocampal neurogenesis and imposes cell-autonomous control of anxiety behaviour from the neurogenic nicheMOLECULAR PSYCHIATRYIF10.12016-11-1555OAAI
Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitorsELIFEIF02016-08-2439OA
Derangement of Ras-Guanine Nucleotide-Releasing Factor 1 (Ras-GRF1) and Extracellular Signal-Regulated Kinase (ERK) Dependent Striatal Plasticity in L-DOPA-Induced DyskinesiaBIOLOGICAL PSYCHIATRYIF92015-01-0162OAAI
JNK1 controls dendritic field size in L2/3 and L5 of the motor cortex, constrains soma size, and influences fine motor coordinationFRONTIERS IN CELLULAR NEUROSCIENCEIF42014-09-1231OAAI